142 related articles for article (PubMed ID: 10870026)
21. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
Venkataraman GM; Yatin M; Marcinek R; Ain KB
J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
[TBL] [Abstract][Full Text] [Related]
22. Drug therapy alternatives in the treatment of thyroid cancer.
O'Doherty MJ; Coakley AJ
Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in treatment of medullary thyroid carcinoma.
Vezzosi D; Bennet A; Caron P
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):147-53. PubMed ID: 17391636
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
[TBL] [Abstract][Full Text] [Related]
25. A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma.
Barzon L; Pacenti M; Taccaliti A; Franchin E; Bruglia M; Boscaro M; Palù G
J Clin Endocrinol Metab; 2005 May; 90(5):2831-4. PubMed ID: 15713704
[TBL] [Abstract][Full Text] [Related]
26. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
Zhang R; Straus FH; DeGroot LJ
Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
[TBL] [Abstract][Full Text] [Related]
27. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
Sobotková E; Dusková M; Smahel M; Holán V; Janousková O; Vonka V
Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors.
Block A; Chen SH; Kosai K; Finegold M; Woo SL
Pancreas; 1997 Jul; 15(1):25-34. PubMed ID: 9211489
[TBL] [Abstract][Full Text] [Related]
31. Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3',5'-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells.
Kitazono M; Chuman Y; Aikou T; Fojo T
J Clin Endocrinol Metab; 2001 Feb; 86(2):834-40. PubMed ID: 11158054
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
[TBL] [Abstract][Full Text] [Related]
33. Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells.
Miyauchi M; Yoshida Y; Tada Y; Narita M; Maeda T; Bahar R; Kadomatsu K; Muramatsu T; Matsubara S; Nakagawara A; Sakiyama S; Tagawa M
Int J Cancer; 2001 Mar; 91(5):723-7. PubMed ID: 11267987
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study.
Simon D; Körber C; Krausch M; Segering J; Groth P; Görges R; Grünwald F; Müller-Gärtner HW; Schmutzler C; Köhrle J; Röher HD; Reiners C
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):775-82. PubMed ID: 12029551
[TBL] [Abstract][Full Text] [Related]
35. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.
Braiden V; Nagayama Y; Iitaka M; Namba H; Niwa M; Yamashita S
Endocrinology; 1998 Sep; 139(9):3996-9. PubMed ID: 9724055
[TBL] [Abstract][Full Text] [Related]
36. Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system.
Nagayama Y; Nishihara E; Iitaka M; Namba H; Yamashita S; Niwa M
Cancer Res; 1999 Jul; 59(13):3049-52. PubMed ID: 10397242
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway.
Kitazono M; Chuman Y; Aikou T; Fojo T
Int J Cancer; 2002 May; 99(3):453-9. PubMed ID: 11992417
[TBL] [Abstract][Full Text] [Related]
38. Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer.
Pizzato M; Franchin E; Calvi P; Boschetto R; Colombo M; Ferrini S; Palù G
Gene Ther; 1998 Jul; 5(7):1003-7. PubMed ID: 9813672
[TBL] [Abstract][Full Text] [Related]
39. A perspective view of sodium iodide symporter research and its clinical implications.
Riesco-Eizaguirre G; Santisteban P
Eur J Endocrinol; 2006 Oct; 155(4):495-512. PubMed ID: 16990649
[TBL] [Abstract][Full Text] [Related]
40. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
